IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Deep Track Capital, LP

Q2 2023 Holdings

Filed 2023-08-14 | 55 holdings | $2.2B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2023-09-06) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$110.0M2,646,7825.1%
Travere Therapeutics Inc(TVTX)COM89422G107$113.2M7,370,0005.2%
Ionis Pharmaceuticals Inc(IONS)COM462222100$116.3M2,834,0695.4%
Insmed Inc(INSM)COM PAR $.01457669307$137.2M6,500,0006.3%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$155.0M1,250,0007.2%
PreviousPage 2 of 2